| Bone fractures and treatments | Lifetime | 30 | CN 1 | 99.67 |
| Cancer-related molecular mechanisms research | Lifetime | 82 | CN 29 | 99.54 |
| Mesenchymal stem cell research | Lifetime | 34 | CN 4 | 99.68 |
| MicroRNA in disease regulation | Lifetime | 113 | CN 34 | 99.43 |
| Circular RNAs in diseases | Lifetime | 96 | CN 51 | 99.17 |
| Cancer Mechanisms and Therapy | Lifetime | 65 | CN 5 | 99.08 |
| Tissue Engineering and Regenerative Medicine | Lifetime | 187 | CN 11 | 98.78 |
| Epigenetics and DNA Methylation | Lifetime | 588 | CN 41 | 98.59 |
| Cancer-related Molecular Pathways | Lifetime | 425 | CN 18 | 98.50 |
| Cancer-related gene regulation | Lifetime | 370 | CN 36 | 98.06 |
| Cancer Cells and Metastasis | Lifetime | 506 | CN 27 | 97.86 |
| Craniofacial Disorders and Treatments | Lifetime | 160 | CN 4 | 97.99 |
| Wnt/β-catenin signaling in development and cancer | Lifetime | 220 | CN 8 | 97.17 |
| Bone Metabolism and Diseases | Lifetime | 317 | CN 12 | 97.87 |
| Extracellular vesicles in disease | Lifetime | 468 | CN 141 | 96.39 |
| Connective tissue disorders research | Lifetime | 243 | CN 7 | 96.85 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 557 | CN 29 | 97.55 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 385 | CN 15 | 97.01 |
| Bone health and treatments | Lifetime | 901 | CN 20 | 96.31 |
| Tendon Structure and Treatment | Lifetime | 680 | CN 32 | 95.73 |
| Chemokine receptors and signaling | Lifetime | 447 | CN 14 | 94.33 |
| Ferroptosis and cancer prognosis | Lifetime | 920 | CN 553 | 92.69 |
| Melanoma and MAPK Pathways | Lifetime | 487 | CN 13 | 95.33 |
| TGF-β signaling in diseases | Lifetime | 723 | CN 61 | 91.42 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 220 | CN 144 | 86.69 |
| Phytochemical compounds biological activities | Lifetime | 681 | CN 131 | 90.95 |
| Hippo pathway signaling and YAP/TAZ | Lifetime | 791 | CN 86 | 88.67 |
| Mechanisms of cancer metastasis | Lifetime | 298 | CN 47 | 80.87 |
| Planarian Biology and Electrostimulation | Lifetime | 517 | CN 22 | 81.56 |
| GDF15 and Related Biomarkers | Lifetime | 764 | CN 58 | 76.64 |
| FOXO transcription factor regulation | Lifetime | 812 | CN 166 | 76.31 |
| Mesenchymal stem cell research | 2021-2025 | 21 | CN 11 | 98.35 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 61 | CN 15 | 98.12 |
| Cancer-related molecular mechanisms research | 2021-2025 | 343 | CN 264 | 97.15 |
| Tissue Engineering and Regenerative Medicine | 2021-2025 | 189 | CN 70 | 92.85 |
| Bone Metabolism and Diseases | 2021-2025 | 98 | CN 37 | 92.09 |
| MicroRNA in disease regulation | 2021-2025 | 763 | CN 466 | 92.54 |
| Extracellular vesicles in disease | 2021-2025 | 757 | CN 449 | 91.06 |
| Ferroptosis and cancer prognosis | 2021-2025 | 908 | CN 769 | 90.15 |
| Circular RNAs in diseases | 2021-2025 | 561 | CN 401 | 89.91 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 988 | CN 199 | 85.83 |
| Periodontal Regeneration and Treatments | 2021-2025 | 640 | CN 74 | 83.51 |
| Connective tissue disorders research | 2021-2025 | 345 | CN 41 | 78.78 |
| Cell Adhesion Molecules Research | 2021-2025 | 922 | CN 128 | 68.97 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 676 | CN 157 | 64.33 |
| Macrophage Migration Inhibitory Factor | 2021-2025 | 236 | CN 77 | 59.57 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 530 | CN 137 | 57.40 |
| GDF15 and Related Biomarkers | 2021-2025 | 663 | CN 110 | 51.91 |
